Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Accounts Payables: 2018-2025

Historic Accounts Payables for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $9.9 million.

  • Verastem's Accounts Payables rose 122.80% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 122.80%. This contributed to the annual value of $4.0 million for FY2024, which is N/A change from last year.
  • Per Verastem's latest filing, its Accounts Payables stood at $9.9 million for Q3 2025, which was up 22.88% from $8.0 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Accounts Payables registered a high of $9.9 million during Q3 2025, and its lowest value of $641,000 during Q3 2021.
  • Its 3-year average for Accounts Payables is $6.2 million, with a median of $5.9 million in 2023.
  • Per our database at Business Quant, Verastem's Accounts Payables tumbled by 86.31% in 2021 and then skyrocketed by 736.04% in 2022.
  • Quarterly analysis of 5 years shows Verastem's Accounts Payables stood at $2.3 million in 2021, then surged by 112.90% to $4.9 million in 2022, then declined by 4.50% to $5.1 million in 2023, then dropped by 13.29% to $4.0 million in 2024, then skyrocketed by 122.80% to $9.9 million in 2025.
  • Its Accounts Payables was $9.9 million in Q3 2025, compared to $8.0 million in Q2 2025 and $7.2 million in Q1 2025.